The vaccine race
4 years, 5 months ago

The vaccine race

The Hindu  

ON January 11, the genetic sequence of the virus causing the outbreak of the respiratory disease in Wuhan, China, was posted by a team at Fudan University in Shanghai on GenBank, a global online database maintained by the United States’ National Institutes of Health. Within three months, a period equivalent to travelling at the speed of light for vaccine development, the Oxford SARS-CoV-2 vaccine was in the first stage of human clinical trials. The speed was partly possible because Moderna, like the Oxford team, had been developing a vaccine for MERS and was able to switch the MERS spike protein with the SARS-CoV-2 virus protein. One of them, CanSino, a Tianjin-based company, like the Oxford team, used recombinant viral vector technology to create a vaccine which had its first human trials in mid March as well and is now undergoing phase 2 clinical trials. The U.S. government has invested $1.2 billion in the vaccine that Oxford University is developing, an amount that will pay for the remaining costs of developing the vaccine, manufacturing enough doses for clinical trials in the U.S., as well as at least part of the cost of “at risk manufacturing”, or beginning to manufacture hundreds of thousands of doses of a candidate vaccine before clinical trials are completed, so that if the trials are successful the vaccine will be available immediately to the public.

History of this topic

Phase-3 clinical trial of India's first dengue vaccine begins at KIMS-Bhubaneswar
3 months, 3 weeks ago
Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
3 months, 3 weeks ago
‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago
With State prod, India can be world leader in vaccines
10 months, 4 weeks ago
How India’s Vaccine Industry Will Save Millions of Children in Africa - News18
1 year, 2 months ago
The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine
1 year, 2 months ago
A new TB vaccine could save 8.5m lives over the next quarter of a century
1 year, 5 months ago
A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago
India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago
Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns
1 year, 8 months ago
‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 9 months ago
Covid vaccine mission is a lesson for the world
1 year, 9 months ago
Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India
1 year, 10 months ago
COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 10 months ago
Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1
1 year, 10 months ago
Nasal vaccine at govt centres in Delhi from Feb 15
1 year, 10 months ago
India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago
What is nasal vaccine - iNCOVACC? All you need to know
1 year, 10 months ago
Centre rolls out first nasal Covid vaccine as booster
1 year, 10 months ago
Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
1 year, 10 months ago
Private hospitals with advance orders to get intranasal COVID-19 shots soon
1 year, 10 months ago
India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
1 year, 10 months ago
COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago
Bharat Biotech’s nasal vaccine likely to be launched on Jan 26
1 year, 11 months ago
First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
1 year, 11 months ago
Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago
Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy
1 year, 11 months ago
Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago
Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
1 year, 11 months ago
Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
1 year, 11 months ago
Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know
2 years ago
Bharat Biotech’s nasal vaccine to be available as booster dose
2 years ago
COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago
Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago
World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use
2 years ago
More vaccine choices: The Hindu Editorial on Bharat Biotech’s intranasal COVID-19 vaccine
2 years ago
Bharat Biotech's intranasal vaccine gets approval as heterologous booster
2 years ago
Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster
2 years ago
How the COVID-19 pandemic altered the vaccine story in India
2 years, 2 months ago
AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago
Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago
Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 3 months ago
India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 3 months ago
Monkeypox vaccines: India puts emergency buying on hold for now - here’s why
2 years, 3 months ago
India to launch first indigenous vaccine against cervical cancer on Sept 1
2 years, 3 months ago
Tackling the new variants
2 years, 4 months ago
Bharat Biotech completes clinical development for phase III trials, booster doses for BBV154 intranasal COVID vaccine
2 years, 4 months ago
COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech
2 years, 4 months ago
Monkeypox: 8 Indian firms express interest in developing vaccine
2 years, 4 months ago
Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine this month
2 years, 4 months ago

Discover Related